We analyse and interpret information in a variety of ways.
Prescription cost analysis
These are analysed by British National Formulary (BNF) Therapeutic Class. One prescription item is a single item written on a prescription form, known as an FP10. This publication shows greatest granularity per prescription item.
Data is analysed for:
- number of items dispensed
- net ingredients costs
- free versus charged prescribing
- trends in prescribing by therapeutic area
- trends in volumes of prescribing and shifts in cost
This analysis is interpreted as change against the same figures in recent years to portray trends over the last 10 years.
Prescribing costs in hospitals and the community
Costs from the drug tariff and standard price lists by net ingredient costs are applied to the data. However, trusts often access NHS negotiated price discounts, so these costs are not necessarily truly reflective of what the NHS paid. The costs are compared to the previous year and expressed as percentage annual increase or decrease.
Prescribing for diabetes in England
Prescribing for diabetes examines prescribing trends on medicines prescribed in primary care in England for the treatment and monitoring of diabetes over a 10-year period. This is analysed as a proportion of the total prescribing spend in the UK and split by BNF classifications for differing types of diabetes drugs by number of items and cost.
The prescribing data is interpreted against the prevalence of diabetes over time by financial year and down to CCG level.
The data is analysed by product, condition and geography. The analysis is compared against previous years to monitor the change of use, with the headline interpretation being whether more of these innovative technologies are being used in relation to the previous report.
General pharmaceutical services: England
Information about NHS services provided by community pharmacies and appliance contractors in England is analysed. The number of sites, the number of prescriptions, the fees charged, and the average fees are all analysed. The number of dispensed medicines via community pharmacy, appliance contractors and dispensing GPs is aggregated by region.